Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$418.69 - $503.0 $90,437 - $108,648
-216 Reduced 29.63%
513 $245,000
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $304,932 - $395,360
-867 Reduced 54.32%
729 $306,000
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $766,592 - $1.05 Million
-1,858 Reduced 53.79%
1,596 $666,000
Q2 2022

Aug 12, 2022

BUY
$463.67 - $597.16 $1.36 Million - $1.75 Million
2,927 Added 555.41%
3,454 $1.71 Million
Q1 2022

May 12, 2022

SELL
$524.57 - $735.42 $778,461 - $1.09 Million
-1,484 Reduced 73.79%
527 $297,000
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $1.43 Million - $1.6 Million
2,011 New
2,011 $1.52 Million
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $1.43 Million - $1.79 Million
-2,167 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $2.66 Million - $2.99 Million
-4,607 Reduced 68.01%
2,167 $1.4 Million
Q1 2021

May 06, 2021

BUY
$547.01 - $662.35 $3.71 Million - $4.49 Million
6,774 New
6,774 $3.87 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $529,575 - $667,257
-1,037 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $471,243 - $555,417
1,037 New
1,037 $535,000
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $567,520 - $664,205
-1,775 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$304.55 - $345.24 $1.04 Million - $1.18 Million
-3,409 Reduced 65.76%
1,775 $591,000
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $44,187 - $48,138
154 Added 3.06%
5,184 $1.62 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $806,807 - $1.14 Million
3,597 Added 251.01%
5,030 $1.54 Million
Q4 2018

Feb 12, 2019

BUY
$220.1 - $309.0 $315,403 - $442,797
1,433 New
1,433 $333,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.